Abstract
Previous studies have demonstrated that when cells of the mouse osteoblastic cell line MC3T3-E1 are exposed to IGF-I and IGF-II they exhibit rapid and transient induction of the transcript from the proto-oncogene c-fos [8]. To clarify the relationship between induction of cell proliferation and proto-oncogene expression in MC3T3-E1 cells, the acute affects of IGF-I and IGF-II, growth factors that stimulate cell proliferation, and of TGF-β1, which inhibits cell proliferation, northern analyses with cDNA-derived probes for the proto-oncogenes c-jun, jun-B, and jun-D were undertaken. Concurrent northern analyses with a probe for c-fos extended our previous results to include the effect of TGF-β1 on c-fos. IGF-I does not induce the c-jun, jun-B, or jun-D transcripts, the former and latter being produced at detectable levels constitutively. After 1 hour of exposure to IGF-II the c-jun transcript response ranges from onefold to 13-fold and the jun-D transcript response ranges around twofold. After 1 hour of exposure to TGF-β1, the jun-B transcript response ranges from eightfold to 24-fold, the c-fos transcript response ranges between sixfold and sevenfold. The differences observed in the magnitude and kinetics of the induction provoked by these growth factors is consistent with the presence of a regulatory circuit acting through the Jun family members which may act to stimulate transcription differentially when bound to DNA either as homodimers or, with Fos family proteins, as heterodimers.
Similar content being viewed by others
References
Ransone LJ, Verma IM (1989) Association of nuclear oncoproteins Fos and Jun. Cur Opin Cell Biol 1:536–540
Gutman A, Wasylyk B (1991) Nuclear targets for transcription regulation by oncogenes. Trends Gene 7:49–54
Riabowol K, Schiff J, Gilman MZ (1992) Transcription factor AP-1 activity is required for initiation of DNA synthesis and is lost during cellular aging. Proc Natl Acad Sci USA 89:157–161
Kovary K, Bravo R (1992) Existence of different Fos/Jun complexes during the G0-to-G1 transition and during exponential growth in mouse fibroblasts: differential role of Fos proteins. Mol Cell Biol 12:5015–5023
Shemshedini L, Knauthe R, Saaone-Corsi P, Pornon A, Gronemeyer H (1991) Cell-specific inhibitory and stimulatory effects of Fos and Jun on transcription activation by nuclear receptors. EMBO 10:3839–3849
Wang Z-Q, Ovitt C, Grigoriadis AE, Mohle-Steinlein U, Ruther U, Wagner EF (1992) Bone and haematopoietic defects in mice lacking c-fos. Nature 360:741–745
Smeyne RJ, Venrell M, Haywood M, Baker SJ, Miao GG, Schilling K, Robertson LM, Curran T, Morgan JI (1993) Continuous c-fos expression precedes programmed cell death in vivo. Nature 363:166–169
Merriman HL, LaTour DA, Linkhart TA, Mohan S, Baylink DJ, Strong DD (1990) Insulin-like growth factor-I and insulinlike growth factor-II induce c-fos in mouse osteoblastic cells. Calcif Tissue Int 46:258–262
Candeliere GA, Prud'homme J, St-Arnaud R (1991) Differential stimulation of Fos and Jun family members by calcitriol in osteoblastic cells. Mol Endocrinol 5:1780–1788
Okazaki R, Ikeda K, Sakamoto A, Nakano T, Morimoto K, Kikuchi T, Urakawa K, Ogata E, Matsumoto T (1992) Transcriptional activation of c-fos and c-jun protooncogenes by serum growth factors in osteoblast-like MC3T3-E1 cells. J Bone Miner Res 7:1149–1155
Amarnani S, Merriman HL, Linkhart TA, Baylink DJ, Mohan S (1993) Autocrine regulators of MC3T3-E1 cell proliferation. J Bone Miner Res 8:157–165
Mohan S, Baylink DJ (1991) Bone growth factors. Clin Orthop 263:30–48
Mohan S, Jennings JJ, Linkhart TA, Baylink DJ (1988) Primary structure of human skeletal growth factor: homology with human insulin-like growth factor-II. Biochim Biophys Acta 966: 44–55
Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K (1989) Current protocols in molecular biology. John Wiley & Sons, London, New York
Feinberg AP, Vogelstein B (1983) A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132:6–13
Lamph WW, Wamsley P, Sassone-Corsi P, Verma IM (1988) Induction of proto-oncogene Jun/AP1 by serum and TPA. Nature 334:629–631
Harpold MM, Evans RM, Salditt-Georgieff M, Darnell JE (1979) Production of mRNA in Chinese hamster cells: relationship of the rate of synthesis to the cytoplasmic concentration of nine specific mRNA sequences. Cell 17:1025–1035
Kasperk CH, Wergedal JE, Mohan S, Long DL, Lau KHW, Baylink DJ (1990) Interactions of growth factors present in bone matrix with bone cells: effects on DNA synthesis and alkaline phosphatase. Growth Factors 3:147–158
Mohan S, Linkhart TA, Rosenfeld R, Baylink DJ (1989) Characterization of the receptor for insulin-like growth factor II in bone cells. J Cell Physiol 140:169–176
Elford PR, Guenther HL, Felix R, Cecchini MG, Fleisch (1987) Transforming growth factor β reduces the phenotypic expression of osteoblastic MC3T3-E1 cells in monolayer culture. Bone 8:259–262
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Strong, D.D., Merriman, H.L., Landale, E.C. et al. The effects of the insulin-like growth factors and transforming growth factor β on the jun proto-oncogene family in MC3T3-E1 cells. Calcif Tissue Int 55, 311–315 (1994). https://doi.org/10.1007/BF00310411
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00310411